Johnson & Johnson ordered to pay man $8bn over breast growth
US drug firm Johnson & Johnson
has been told to pay $8bn (£6.6bn) in punitive damages to a man over claims he was not warned that an anti-psychotic drug could lead to breast growth.
A Philadelphia jury
made the award to Nicholas Murray, 26, whose case was one of thousands pending in the state.
His lawyers
argued J&J’s subsidiary Janssen put “profits over patients” in marketing the drug Risperdal.
BBC News